Kenneth B. Lee
Kenneth B. Lee, Jr. serves as a member of the Board of Directors of Aralez Pharmaceuticals Inc. and served in this role with the company’s predecessor, POZEN Inc., since December 2002. He is chairman of the compensation committee and a member of the audit committee. Mr. Lee is a managing member of Hatteras Venture Partners, a venture capital fund focusing on life sciences companies. Mr. Lee spent 29 years with Ernst & Young, primarily in the Palo Alto Office. He ran the Firms Life Sciences Practice in the US and was Co-Chair of the International Life Sciences Practice. He is a co-founder of the National Conference on Biotechnology Ventures and co-authored the Ernst & Young Life Sciences Annual Report for many years. and serves as a director of CV Therapeutics and Abgenix and Inspire Pharmaceuticals. Mr. Lee also advised biotechnology and pharmaceutical companies throughout the world on a wide range of financial and strategic planning issues. After retiring from Ernst & Young, he served on the boards of Abgenix, CV Therapeutics, Inspire Pharmaceuticals, Maxygen and OSI Pharmaceuticals. Mr. Lee currently serves on the boards of Aralez and Biocryst Pharmaceuticals.